Advertisement
Advertisement
IKT
Inhibikase Therapeutics, Inc. Common Stock
2.15
USDSponsored
-0.16
-6.93%
Sep 23, 15:45 UTC -4
Closed
After-Market
2.15
0.00
+0.23%
Inhibikase Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 300.70M |
| Beta | 0.95 |
| Earnings Per Share (EPS) | -0.43 |
| Price-to-Book (P/B) Ratio | 1.89 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -42.80% |
| Current Ratio | 15.82% |
| Free Cash Flow | -24.50M |
